Epilepsy Advocate App

Epilepsy is a chronic neurological disorder affecting approximately 65 million people worldwide and over two million people in the U.S. The disorder’s chronic nature increases the ongoing need for patient empowerment and support; this led UCB to launch the Epilepsy Advocate initiative in 2004. That program now features an ecosystem of platforms, including the largest U.S. epilepsy community on Facebook, a YouTube channel featuring original interviews with advocates, a website full of educational materials, and a printed magazine with original journalistic content which gets distributed to physician’s offices.

UCB partnered with Mobiquity Inc. – a trusted mobile engagement provider – to create a mobile experience to deliver the great EpilepsyAdvocate journalistic content into the digital realm. The companies worked closely together to determine the most desired and needed features of patients living with epilepsy that don’t appear in other apps targeted at this audience. The joint effort resulted in the “EpilepsyAdvocate App,” a mobile resource that helps patients get inspired, set their goals, and find support on their journey of living with epilepsy. The app features:

• Inspiring personal stories from people making a difference in the epilepsy community
• Educational articles, with tips and ideas to help the patient handle his or her epilepsy journey
• Tools to help patients set goals, stick to them, and share their success
• A select list of websites where the patient can find information and support
• An interactive article finder to select the perfect story based on an individual’s current needs.

Epilepsy Advocate is free to all users. The application is available in the U.S. in both the Google Play and Apple App Stores.

<a href="http://atlantamobileawards.com/wp-content/uploads/sites/3/2015/08/unnamed more tips here.jpg”>unnamedunnamed (1)
0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *